Doris Benbrook to Mutagenicity Tests
This is a "connection" page, showing publications Doris Benbrook has written about Mutagenicity Tests.
Connection Strength
0.124
-
Development of flexible-heteroarotinoids for kidney cancer. Mol Cancer Ther. 2009 May; 8(5):1227-38.
Score: 0.082
-
Genotoxicity of the cancer chemopreventive drug candidates CP-31398, SHetA2, and phospho-ibuprofen. Mutat Res. 2012 Jul 04; 746(1):78-88.
Score: 0.025
-
Effects of norfloxacin on DNA metabolism in Pseudomonas aeruginosa. Antimicrob Agents Chemother. 1986 Jan; 29(1):1-6.
Score: 0.016